Boireau A - Search Results

1

Blanchard JC, Boireau A, Julou L. Blanchard JC, et al. Among authors: boireau a. Pharmacology. 1983;27 Suppl 2:59-69. doi: 10.1159/000137912. Pharmacology. 1983. PMID: 6322210

2

Brain receptors and zopiclone.

Blanchard JC, Boireau A, Julou L. Blanchard JC, et al. Among authors: boireau a. Int Pharmacopsychiatry. 1982;17 Suppl 2:59-69. Int Pharmacopsychiatry. 1982. PMID: 6329982

3

In vitro and in vivo inhibition by zopiclone of benzodiazepine binding to rodent brain receptors.

Blanchard JC, Boireau A, Garret C, Julou L. Blanchard JC, et al. Among authors: boireau a. Life Sci. 1979 Jun 25;24(26):2417-20. doi: 10.1016/0024-3205(79)90449-1. Life Sci. 1979. PMID: 39209 No abstract available.

4

Preferential decrease in dopamine utilization in prefrontal cortex by zopiclone, diazepam and zolpidem in unstressed rats.

Boireau A, Dubedat P, Laduron PM, Doble A, Blanchard JC. Boireau A, et al. J Pharm Pharmacol. 1990 Aug;42(8):562-5. doi: 10.1111/j.2042-7158.1990.tb07059.x. J Pharm Pharmacol. 1990. PMID: 1981584

5

In vivo determination of the profile of benzodiazepine ligands by comparing the inhibition of 3H-Ro 15-1788 binding to the modulation of cGMP levels in mouse cerebellum.

Boireau A, Martel M, Farges G, Dubédat P, Laduron PM, Blanchard JC. Boireau A, et al. Biochem Pharmacol. 1988 Oct 1;37(19):3765-9. doi: 10.1016/0006-2952(88)90413-3. Biochem Pharmacol. 1988. PMID: 2845996

6

The use of thioproperazine, a phenothiazine derivative, as a ligand for neuroleptic receptors--I. In vitro studies.

Blanchard JC, Boireau A, Garret C, Julou L. Blanchard JC, et al. Among authors: boireau a. Biochem Pharmacol. 1980 Nov 1;29(21):2933-8. doi: 10.1016/0006-2952(80)90040-4. Biochem Pharmacol. 1980. PMID: 6109531 No abstract available.

7

The use of thioproperazine, a phenothiazine derivative, as a ligand for neuroleptic receptors--II. In vivo studies.

Boireau A, Blanchard JC, Garret C, Julou L. Boireau A, et al. Biochem Pharmacol. 1980 Nov 1;29(21):2939-42. doi: 10.1016/0006-2952(80)90041-6. Biochem Pharmacol. 1980. PMID: 6109532 No abstract available.

8

Suriclone, a new anxiolytic of the cyclopyrrolone family: evidence for possible interference with GABAergic systems.

Boireau A, Stutzmann JM, Garret C, Julou L, Blanchard JC. Boireau A, et al. Eur J Pharmacol. 1984 Sep 3;104(1-2):139-44. doi: 10.1016/0014-2999(84)90380-7. Eur J Pharmacol. 1984. PMID: 6149942

9

Neuroprotective effects of RPR 104632, a novel antagonist at the glycine site of the NMDA receptor, in vitro.

Boireau A, Malgouris C, Burgevin MC, Pény C, Durand G, Bordier F, Meunier M, Miquet JM, Daniel M, Chevet T, Jimonet P, Mignani S, Blanchard JC, Doble A. Boireau A, et al. Eur J Pharmacol. 1996 Apr 11;300(3):237-46. doi: 10.1016/0014-2999(95)00780-6. Eur J Pharmacol. 1996. PMID: 8739214

10

Enhancing effect of dopamine blockers on evoked acetylcholine release in rat striatal slices: a classical D-2 antagonist response?

Boireau A, Chambry J, Dubedat P, Farges G, Carruette AM, Zundel JL, Blanchard JC. Boireau A, et al. Eur J Pharmacol. 1986 Aug 22;128(1-2):93-8. doi: 10.1016/0014-2999(86)90562-5. Eur J Pharmacol. 1986. PMID: 2875894

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters